BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23202320)

  • 1. PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.
    Krakauer T
    Toxins (Basel); 2012 Nov; 4(11):1343-66. PubMed ID: 23202320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.
    Krakauer T
    Toxins (Basel); 2010 Aug; 2(8):1963-83. PubMed ID: 22069668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock.
    Krakauer T
    Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30909619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.
    Krakauer T
    Toxins (Basel); 2013 Sep; 5(9):1629-54. PubMed ID: 24064719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutics targeting immune activation by staphylococcal superantigens.
    Krakauer T
    Med Sci Monit; 2005 Sep; 11(9):RA290-5. PubMed ID: 16127375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal Superantigens Spark Host-Mediated Danger Signals.
    Krakauer T; Pradhan K; Stiles BG
    Front Immunol; 2016; 7():23. PubMed ID: 26870039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to staphylococcal superantigens.
    Krakauer T
    Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights.
    Krakauer T
    Immunotargets Ther; 2017; 6():17-29. PubMed ID: 28497030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide antagonists of superantigen toxins.
    Kaempfer R
    Mol Divers; 2004; 8(2):113-20. PubMed ID: 15209162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
    Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production.
    Krakauer T
    Immunol Lett; 1994 Feb; 39(2):121-5. PubMed ID: 8013959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
    Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
    J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal and Streptococcal Superantigens Trigger B7/CD28 Costimulatory Receptor Engagement to Hyperinduce Inflammatory Cytokines.
    Popugailo A; Rotfogel Z; Supper E; Hillman D; Kaempfer R
    Front Immunol; 2019; 10():942. PubMed ID: 31114583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal enterotoxin C2 mutant drives T lymphocyte activation through PI3K/mTOR and NF-ĸB signaling pathways.
    Fu X; Xu M; Yao S; Zhang H; Zhang C; Zhang J
    Toxicol Appl Pharmacol; 2017 Oct; 333():51-59. PubMed ID: 28807764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.